Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts Seven companies have been shortlisted for the Orphan Product Award; Amicus (Galafold), Biogen (Spinraza), Biomarin (Brineura), Eusa (Qarziba), Intercept (Ocaliva), Kyowa Kirin (Crysvita) and Shire (Revestive).

Freeline raises £88m to accelerate haemophilia gene therapy

Freeline raises £88m to accelerate haemophilia gene therapy Following after is Sangamo with SB-FIX in phase I/II testing. Baxalta (now part of Shire) was an early player in the field with its BAX 335 therapy, but has

Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report The planned merger of Takeda with Shire – assuming it goes ahead – would propel the combined company to ninth place based on 2024 sales.

Prevail Therapeutics adds to its board of directors

Prevail Therapeutics adds to its board of directors From 2008-2015 Nader was president and chief executive officer of NPS Pharma, until Shire acquired the company for $5.2bn.

BioMarin ups the ante for pivotal haemophilia gene therapy trial

BioMarin ups the ante for pivotal haemophilia gene therapy trial In the chase are Spark Therapeutics’ SPK-8011, Pfizer/Sangamo Biosciences’ SB-525 and Shire’s SHP654 - all in phase I/II testing - with uniQure and Sanofi’s Bioverativ unit also

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics